WuXi AppTec Completes HK$1.5 Billion H Share Acquisition for Employee Incentive Scheme

WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has issued an update.

WuXi AppTec Co., Ltd. announced the completion of the acquisition of H Shares worth HK$1.5 billion under the 2025 H Share Award and Trust Scheme. This acquisition, which represents approximately 0.73% of the company’s total issued share capital, aims to incentivize core employees by granting them Award Shares upon meeting specific revenue targets. The move is part of WuXi AppTec’s strategy to align employee interests with company performance, although there remains uncertainty about meeting the revenue conditions required for the grant.

The most recent analyst rating on (HK:2359) stock is a Hold with a HK$51.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.

More about WuXi AppTec Co., Ltd. Class H

WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical and biotechnology industry. The company provides comprehensive laboratory and manufacturing services that enable pharmaceutical, biotech, and medical device companies to advance their research and development efforts.

Average Trading Volume: 8,546,710

Technical Sentiment Signal: Buy

Current Market Cap: HK$202B

See more insights into 2359 stock on TipRanks’ Stock Analysis page.